BRANDON CARLISLE: Open Payments
NPI 1407212699 · ROANOKE RAPIDS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,365 in 79 payments from 16 companies in 2025. Trend: 2023 $1,608 · 2024 $1,649 · 2025 $1,365
Food & beverage: $1,365
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $259 |
| AstraZeneca Pharmaceuticals LP | 12 | $230 |
| ABBVIE INC. | 14 | $221 |
| Otsuka America Pharmaceutical, Inc. | 6 | $101 |
| Lilly USA, LLC | 6 | $99 |
| Lundbeck LLC | 4 | $77 |
| Corcept Therapeutics | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $62 |
| Exact Sciences Corporation | 3 | $53 |
| Amgen Inc. | 3 | $50 |
Products named: REXULTI, FARXIGA, Wegovy, Ozempic, AIRSUPRA, MOUNJARO, UBRELVY, JARDIANCE.
Industry payments across NC — which companies pay providers there.
